• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dr. Marty Makary advances out of key committee in bid for FDA confirmation

by March 13, 2025
written by March 13, 2025

President Donald Trump’s nominee to lead the Food and Drug Administration (FDA), Dr. Marty Makary, passed a key committee vote 14-9 on Thursday morning, clearing the way for a full Senate vote on his nomination. 

If confirmed before the full Senate, Makary will work alongside the nominee for National Institute of Health (NIH) Director Dr. Jay Bhattacharya to achieve Secretary of Health and Human Services Robert F. Kennedy Jr.’s Make America Healthy Again agenda. 

The Senate Committee on Health, Education, Labor and Pensions(HELP) voted in favor of Makary’s confirmation following his committee hearing one week ago today. 

‘We now have a generational opportunity in American healthcare. President Trump and Secretary Kennedy’s focus on healthy foods has galvanized a grassroots movement in America. Childhood obesity is not a willpower problem, and the rise of early-onset Alzheimer’s is not a genetic cause. We should be, and we will, be addressing food as it impacts our health,’ Makary said last week. 

‘Thanks to the courage of President Trump and Secretary Kennedy, we now have a generational opportunity to usher in radical transparency to facilitate more cures, meaningful treatments and diagnostics at the FDA to help people take care of their own health,’ Makary added.

Makary was grilled by Democrats last week on vaccines, abortion, chronic illness and food safety. When repeatedly asked by Democratic senators on the committee whether he would revoke the approval process for Mifepristone, Makary said any decision on the abortion pill will come down to science. 

‘I have no preconceived plans on Mifepristone policy except to take a solid, hard look at the data and to meet with the professional career scientists who have reviewed the data at the FDA, and to build an expert coalition to review the ongoing data,’ he said. 

Makary, who advocated for natural immunity during the COVID-19 pandemic, flipped a question about vaccine processes around on Sen. Patty Murray, D-Wash., during his confirmation hearing, telling her to ask former President Joe Biden why he skipped a key step when it came to the COVID-19 booster. 

‘So, if you are confirmed, will you commit to immediately reschedule that FDA Vaccine Advisory Committee meeting to get the expert views?’ Sen. Patty Murray, D-Wash., asked Trump’s FDA pick. 

‘I would re-evaluate which topics deserve a convening of the advisory committee members on [Vaccines and Related Biological Products Advisory Committee] and which may not require a convening,’ Makary replied, adding that he was not a part of the decision. 

When asked again by Murray, he said: ‘Well, you can ask the Biden administration that chose not to convene the committee meeting for the COVID vaccine booster.’

He vowed during his committee hearing to lead his own Department of Government Efficiency (DOGE) investigations if confirmed. DOGE has terminated the employment of thousands of probationary HHS employees, including those at the FDA, since Trump took office. 

‘If confirmed, I will do my own independent assessment on personnel. I welcome input on efficiencies at the agency. At the same time, I want to make sure that the scientists and food inspectors and staff, central to the core mission of the agency, have all the resources they need to do their job well,’ Makary said last week. 

Makary has long been a critic of the FDA. He penned an opinion piece in 2021 that called for ‘fresh leadership at the FDA to change the culture at the agency and promote scientific advancement, not hinder it.’

Trump nominated Johns Hopkins School of Medicine professor, pancreatic surgeon and former Fox News medical contributor Dr. Marty Makary for FDA commissioner in November. 

‘I am very pleased to nominate Marty Makary MD, MPH, FACS, for FDA Commissioner,’ Trump said in a statement. ‘FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency.’ 

Trump said that Makary will ‘work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation’s food supply and drugs and biologics being given to our Nation’s youth, so that we can finally address the Childhood Chronic Disease Epidemic.’

Fox News Digital’s Julia Johnson contributed to this report.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
FDA chief counsel who defended abortion pill access under Biden resigns two days into job
next post
Trump’s pick for NIH director clears committee, heads to full Senate vote

related articles

Cambodia to nominate Trump for Nobel Peace Prize...

August 2, 2025

Recess on ice as Republicans hunker down for...

August 1, 2025

Trump moves nuclear submarines weeks after praising sub’s...

August 1, 2025

WATCH: Trump says he is hopeful Hillary Clinton...

August 1, 2025

Iran says it has ‘plenty of scientists’ left...

August 1, 2025

Trump repositions 2 nuclear submarines after ‘highly provocative’...

August 1, 2025

Trump endorses ‘MAGA warrior’ for RNC chairman after...

August 1, 2025

Kavanaugh cites 3 presidents in explaining Supreme Court’s...

August 1, 2025

China’s growing nuclear arsenal aims to break US...

August 1, 2025

Trump ally Bukele’s party amends El Salvador constitution...

August 1, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Long COIN: Coinbase Signal Bullish Reversal, Price Expansion Ahead Amid a Second Quarter in Trading Range

    July 19, 2024
  • 12 Dems join GOP lawmakers to threaten UN funding over ‘ongoing hostility’ to Israel

    October 25, 2024
  • Harris entertains Supreme Court-packing question during town hall, supports ‘some kind of reform’

    October 24, 2024
  • Sam Altman’s OpenAI backing initiative headed by several anti-Trump staff pushing liberal causes

    January 18, 2025
  • S&P 500 futures hold steady as market braces for inflation report and Fed signals

    February 12, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,603)
  • Investing (634)
  • Stock (867)

Latest Posts

  • Trump cabinet picks delight Taiwan, send strong signal to China

    November 13, 2024
  • The S&P 500 and Nasdaq continue last week’s recovery

    August 13, 2024
  • Israeli PM Netanyahu calls President-elect Trump – here’s what they spoke about

    November 6, 2024

Recent Posts

  • Chipotle stock dips 14% as CEO Brian Niccol moves to Starbucks: Is it a buy?

    August 14, 2024
  • Fetterman dismisses questions as another top staffer reportedly jumps ship

    June 4, 2025
  • Judge extends order blocking Musk’s DOGE team from Treasury payment system

    February 15, 2025

Editor’s Pick

  • Biden White House to send $1.25 billion in weapon aid to Ukraine before Trump transition: report

    December 28, 2024
  • SNTG Stock Review: Price History and Forecasts

    September 6, 2024
  • At UN Security Council, Israel’s ambassador slams Iranian hypocrisy

    June 22, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock